Identification of Senior At Risk scale predicts 30-day mortality among older patients with acute heart failure
Por:
Martín-Sánchez FJ, Llopis García G, González-Colaço Harmand M, Fernandez Pérez C, González Del Castillo J, Llorens P, Herrero P, Jacob J, Gil V, Domínguez-Rodriguez A, Rossello X and Miró O
Publicada:
1 ene 2020
Ahead of Print:
27 ago 2018
Categoría:
Critical care and intensive care medicine
Resumen:
Objective: To assess the value of frailty screening tool (Identification of Senior at Risk [ISAR]) in predicting 30-day mortality risk in older patients attended in emergency department (ED) for acute heart failure (AHF).
Design: Observational multicenter cohort study.
Setting: OAK-3 register.
Subjects: Patients aged >= 65 years attended with ADHF in 16 Spanish EDs from January to February 2016.
Intervention: No.
Variables: Variable of study was ISAR scale. The outcome was all-cause 30-day mortality.
Results: We included 1059 patients (mean age 85 +/- 5,9 years old). One hundred and sixty (15.1%) cases had 0-1 points, 278 (26.3%) 2 points, 260 (24.6%) 3 points, 209 (19.7%) 4 points, and 152 (14.3%) 5-6 points of ISAR scale. Ninety five (9.0%) patients died within 30 days. The percentage of mortality increased in relation to ISAR category (lineal trend P value < .001). The area under curve of ISAR scale was 0.703 (95%Cl 0.655-0.751; P<.001). After adjusting for EFFECT risk categories, we observed a progressive increase in odds ratios of ISAR scale groups compared to reference (0-1 points).
Conclusions: scale is a brief and easy toot that should be considered for frailty screening during initial assessment of older patients attended with AHF for predicting 30-day mortality. (C) 2018 Elsevier Espana, S.L.U. y SEMICYUC. All rights reserved.
Filiaciones:
Martín-Sánchez FJ:
Servicio de Urgencias, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria, Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, Madrid, España
Llopis García G:
Servicio de Urgencias, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria, Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, Madrid, España
González-Colaço Harmand M:
UCICEC, Servicio de Farmacología Clínica, Hospital Universitario de Canarias, La Laguna, Tenerife, España
Fernandez Pérez C:
Servicio de Medicina Preventiva, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria, Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, Madrid, España
González Del Castillo J:
Servicio de Urgencias, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria, Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, Madrid, España
Llorens P:
Servicio de Urgencias, Hospital General de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-Fundación FISABIO), Universidad Miguel Hernández Alicante
Herrero P:
Servicio de Urgencias, Hospital Central de Asturias, Oviedo, Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), España
Jacob J:
Servicio de Urgencias, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España
Gil V:
Área de Urgencias, Hospital Clínic, Institut de Recerca Biomàdica August Pi i Sunyer (IDIBAPS), Universidad de Barcelona, Barcelona, España
Domínguez-Rodriguez A:
Servicio de Cardiología, Hospital Universitario de Canarias, Universidad Europea de Canarias, Facultad de Ciencias de la Salud, La Laguna, Tenerife, España
Rossello X:
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), CIBER de enfermedades CardioVasculares (CIBERCV), Madrid, España
Miró O:
Área de Urgencias, Hospital Clínic, Institut de Recerca Biomàdica August Pi i Sunyer (IDIBAPS), Universidad de Barcelona, Barcelona, España
|